Major deals involving U.S. drugmakers and biotechs over the past decade
Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
Verona Pharma Stock Jumps 21%. It's Being Bought for $10 Billion by Merck.
Merck to Buy Verona Pharma in $10 Billion Deal
Merck to acquire Verona Pharma for $10 billion